⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Contact Levi & Korsinsky by September 14, 2026 to Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Orphan Drugs Market - Global Forecast 2026-2032 Now Available, Analyzes Biologics, Gene Therapy, Small Molecules, and Tissue Therapy
globenewswire.com
ABBV
ALNY
AMGN
BMRA
BMY
GILD
INCY
JNJ
NVS
PFE
REGN
VRTX
Pomerantz LLP Notifies Shareholders of Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN DEADLINE - FINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Regeneron Pharmaceuticals, Inc. to Contact the Firm Today!
accessnewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Before September 14, 2026 – Contact Levi & Korsinsky
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Investors Urged to Contact Levi & Korsinsky for Information Before September 14, 2026 – Regeneron Pharmaceuticals, Inc. (REGN)
accessnewswire.com
REGN
Pomerantz LLP Notifies Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN